GeorgeNathanielMagrathIIIMDMBA
Ophthalmology • Charleston, SCOcular Oncology
Assistant Professor of Ophthalmology
Dr. Magrath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
Medical University of South CarolinaResidency, Ophthalmology, 2011 - 2014- Medical University of South Carolina College of MedicineInternship, Transitional Year, 2010 - 2011
- Medical University of South CarolinaClass of 2010
Certifications & Licensure
SC State Medical License 2011 - 2025
PA State Medical License 2014 - 2016
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea Start of enrollment: 2017 Oct 30
Publications & Presentations
PubMed
- Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study.George Magrath, Joseph Luvisi, Daniel Russakoff, Jonathan Oakley, Emil Anthony Say
American Journal of Ophthalmology. 2025-02-20 - 8 citationsValidation of a Modified National Eye Institute Grading Scale for Corneal Fluorescein Staining.Kenneth Sall, Gary N Foulks, Andrew D Pucker, Karen L Ice, Richard C Zink
Clinical Ophthalmology. 2023-01-01 - 1 citationsResponse of Bacillary Layer Detachment after Chemotherapy for Choroidal Lymphoma.Joseph Luvisi, Susannah Brown, George N Magrath
Ophthalmology. Retina. 2022-12-01
Press Mentions
Opus Genetics Doses First Pediatric Patient in Phase 1/2 Trial for OPGx-LCA5 Gene TherapyFebruary 20th, 2025- Opus Genetics Receives FDA Agreement Under SPA for Phase 3 Trial of APX3330 in Diabetic RetinopathyDecember 19th, 2024
- MELT-300 Demonstrates Successful Procedural Sedation for Cataract Extraction in New ResearchDecember 13th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
